Development Level

Tchem 4 | 1,890
Tclin 4 | 602
Tbio 1 | 10,625

IMPC Term

decreased leukocyte cell numbe... 1 | 54

Disease

Cancer 9 | 2,346
Carcinoma 7 | 2,147
ovarian cancer 6 | 8,484
glioblastoma 5 | 5,572
osteosarcoma 5 | 7,933
Mammary Neoplasms 4 | 410
Prostatic Neoplasms 4 | 471
atypical teratoid / rhabdoid tumor 4 | 4,369
diabetes mellitus 4 | 1,663
lung cancer 4 | 4,466
psoriasis 4 | 6,685
ulcerative colitis 4 | 2,087
Adenoma 3 | 165
Breast cancer 3 | 3,094
Colorectal Neoplasms 3 | 217
Diabetic Retinopathy 3 | 53
Diarrhea 3 | 155
Exanthem 3 | 39
Heart disease 3 | 279
Hemangioma 3 | 35
Kidney disease 3 | 396
Neutropenia 3 | 78
Retinopathy of prematurity 3 | 21
Squamous cell carcinoma 3 | 94
Vascular disease 3 | 281
acute quadriplegic myopathy 3 | 1,157
astrocytic glioma 3 | 2,241
cystic fibrosis 3 | 1,665
dermatomyositis 3 | 933
invasive ductal carcinoma 3 | 2,950
malignant mesothelioma 3 | 3,162
medulloblastoma, large-cell 3 | 6,234
non-small cell lung cancer 3 | 2,798
non-small cell lung carcinoma 3 | 413
oligodendroglioma 3 | 2,849
Acute kidney injury 2 | 65
Adenocarcinoma 2 | 115
Age related macular degeneration 2 | 84
Alzheimer's disease 2 | 644
Anemia 2 | 252
Arthritis 2 | 248
Arthritis, Experimental 2 | 39
Atherosclerosis 2 | 275
Brain Ischemia 2 | 87
Capillary hemangioma 2 | 11
Carcinoma of thyroid 2 | 17
Cardiomegaly 2 | 66
Cerebrovascular disease 2 | 231
Colonic Neoplasms 2 | 126
Congenital Heart Defects 2 | 37
Coronary artery disease 2 | 240
Diabetes Mellitus, Non-Insulin-Dependent 2 | 157
Diabetic Nephropathy 2 | 37
Endometriosis 2 | 535
Esophageal Neoplasms 2 | 67
Head and Neck Neoplasms 2 | 23
Heart failure 2 | 80
Hemangiosarcoma 2 | 18
Hyperglycemia 2 | 120
Hyperplasia 2 | 26
Hypertension 2 | 287
Hypoxia-Ischemia, Brain 2 | 5
Inflammation 2 | 109
Inflammatory bowel disease 2 | 142
Keratitis 2 | 42
Liver disease 2 | 219
Lung Neoplasms 2 | 171
Lung disease 2 | 132
Lung diseases 2 | 48
Myocardial Ischemia 2 | 169
Myocardial Reperfusion Injury 2 | 34
Neoplasm Invasiveness 2 | 127
Neoplasm Metastasis 2 | 138
Neoplasm Recurrence, Local 2 | 23
Osteochondrodysplasias 2 | 15
Ovarian hyperstimulation syndrome 2 | 15
Pancreatic Neoplasm 2 | 79
Peripheral vascular disease 2 | 90
Pick disease 2 | 1,893
Polycythemia 2 | 19
Schizophrenia 2 | 501
Skin Neoplasms 2 | 49
Small cell carcinoma of lung 2 | 45
Squamous cell carcinoma of esophagus 2 | 82
active Crohn's disease 2 | 918
adult high grade glioma 2 | 2,148
breast carcinoma 2 | 1,614
chronic rhinosinusitis 2 | 512
ependymoma 2 | 2,514
glioblastoma multiforme 2 | 347
gliosarcoma 2 | 19
intraductal papillary-mucinous carcinoma (IPMC) 2 | 2,988
lung adenocarcinoma 2 | 2,713
medulloblastoma 2 | 1,524
ovarian neoplasm 2 | 97
pancreatic cancer 2 | 2,300
pediatric high grade glioma 2 | 2,712
posterior fossa group A ependymoma 2 | 1,511
primary pancreatic ductal adenocarcinoma 2 | 1,271
subependymal giant cell astrocytoma 2 | 2,287

Tissue

Blood and immune system 9 | 17,995
Cardiovascular System 9 | 17,958
Digestive Tract 9 | 18,473
Endocrine System 9 | 18,512
Female tissues 9 | 18,647
Liver and Pancreas 9 | 18,136
Male tissues 9 | 17,969
Nervous System 9 | 18,561
Respiratory system 9 | 17,484
Skin and soft tissues 9 | 18,115
Urinary Tract 9 | 18,444

Target Family

Kinase 6 | 634
Non-IDG 2 | 11,971
Transcription Factor 1 | 1,400

Grant Application

1Z01BC011095-01 9 | 9
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Serine/threonine-protein kinase MARK2 MARK2 Tchem Kinase -2.46742 259.6 291
Vascular endothelial growth factor A VEGFA Tclin Non-IDG -4.21581 17832.7 1361
Dual specificity mitogen-activated protein kinase kinase 1 MAP2K1 Tclin Kinase -3.02798 808.6 1868
Epidermal growth factor receptor EGFR Tclin Kinase -3.95948 9318.1 4989
Vascular endothelial growth factor receptor 2 KDR Tclin Kinase -3.61849 4236.1 2079
Hypoxia-inducible factor 1-alpha HIF1A Tchem Transcription Factor -3.45354 3140.4 1347
RAC-alpha serine/threonine-protein kinase AKT1 Tchem Kinase -4.29533 18275.3 3137
Eukaryotic translation initiation factor 5B EIF5B Tbio Non-IDG -2.71112 500.9 107
Ephrin type-B receptor 2 EPHB2 Tchem Kinase -2.63936 472.2 420